Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$30,000.00

Indentification of MNDA modifications and domains involved in regulation of apoptosis

FY 2016-17

Summary
Different stress and/or the damaging of cells can trigger an intracellular mechanism that induces cell death. This mechanism is called ""apoptosis"". It is an important mechanism to get rid of damaged cells which, otherwise, could induce tissue damage or cancer. We previously defined a novel pathway initiating in the nucleus and signalling to the mitochondria that regulates apoptosis of myeloid and granulocytic cells. The central protein involved in this newly identified signalling is the Myeloid Nuclear Differentiation Antigen (MNDA). When MNDA is relocated from the nucleus to the cytoplasm and the membrane of mitochondria, it interacts with and promotes the degradation of the anti-apoptotic factor MCL-1. This relocation of MNDA correlates with a variation of MNDA phosphorylation, which results from the activity of a yet unidentified enzyme (kinase or phosphatase). Since the modification MNDA phosphorylation follows an extracellular stress, we will look into extracellular signalling pathways to identify pathway(s) affecting MNDA phosphorylation. The importance of MNDA phosphorylation pattern in its relocation to the cytoplasm will be questioned by the mutation of MNDA protein. The identification of the enzyme(s) involved in MNDA phosphorylation will be attempted and the mutation of MNDA will be made to avoid the variation of phosphorylation. Then, the relocation of MNDA and influence of MNDA on apoptosis will be tested. Thus, we aim to identify how the function of MNDA is controlled and regions of MNDA important for the control of apoptosis. There are only few examples of such nuclear to mitochondria signalling. This novel field of investigation is growing rapidly and it is attracting more and more interest due to the importance of the control of apoptosis regulation.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
238736-2013
Name nom
Milot, Eric
Department département
Médecine
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2013
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5002
Research subject group en
Genetics
Research subject group fr
Génétique
Research subject en
Molecular genetics
Research subject fr
Génétique moléculaire
Partie
4
Nb partie
5
Application title
Indentification of MNDA modifications and domains involved in regulation of apoptosis
Keyword
NSERC
Application summary
Different stress and/or the damaging of cells can trigger an intracellular mechanism that induces cell death. This mechanism is called ""apoptosis"". It is an important mechanism to get rid of damaged cells which, otherwise, could induce tissue damage or cancer. We previously defined a novel pathway initiating in the nucleus and signalling to the mitochondria that regulates apoptosis of myeloid and granulocytic cells. The central protein involved in this newly identified signalling is the Myeloid Nuclear Differentiation Antigen (MNDA). When MNDA is relocated from the nucleus to the cytoplasm and the membrane of mitochondria, it interacts with and promotes the degradation of the anti-apoptotic factor MCL-1. This relocation of MNDA correlates with a variation of MNDA phosphorylation, which results from the activity of a yet unidentified enzyme (kinase or phosphatase). Since the modification MNDA phosphorylation follows an extracellular stress, we will look into extracellular signalling pathways to identify pathway(s) affecting MNDA phosphorylation. The importance of MNDA phosphorylation pattern in its relocation to the cytoplasm will be questioned by the mutation of MNDA protein. The identification of the enzyme(s) involved in MNDA phosphorylation will be attempted and the mutation of MNDA will be made to avoid the variation of phosphorylation. Then, the relocation of MNDA and influence of MNDA on apoptosis will be tested. Thus, we aim to identify how the function of MNDA is controlled and regions of MNDA important for the control of apoptosis. There are only few examples of such nuclear to mitochondria signalling. This novel field of investigation is growing rapidly and it is attracting more and more interest due to the importance of the control of apoptosis regulation.